Explore 3 Stock Ideas & Industry Insights Download Free Report

News

China Tech Stocks Rally: Baidu's Kunlunxin IPO and XPeng's AI Pivot Drive Renewed Investor Interest

• Baidu Gains on Kunlunxin IPO Reports: A reported $50 billion Hong Kong IPO valuation for the AI chip affiliate boosted investor sentiment.

Vinay Lochav | 30 June 2026

SpaceX Nasdaq-100 Inclusion 2026: What the July 7 Index Addition Means for Passive Fund Flows

• Confirmed July 7 Addition Date: SpaceX's addition to the Nasdaq-100 Index is scheduled for July 7, 2026, with a clear timeline for passive flows.

Vinay Lochav | 30 June 2026

Stock Split Stocks 2026: CrowdStrike's 4-for-1 Split Joins a Wave of Share Price Adjustments

• 4-for-1 Split Effective July 1: CrowdStrike's split timing coincides with a period of exceptionally strong underlying fundamental performance.

Vinay Lochav | 30 June 2026

Insider Selling Watch 2026: CrowdStrike, Netflix, AST SpaceMobile, and Circle Internet Group Insiders Cash Out

• CrowdStrike CEO Sale: CEO George Kurtz sold approximately $3.4 million in shares on June 25, drawing some bearish attention.

Vinay Lochav | 30 June 2026

Electric Vehicle Stock Watch 2026: Rivian's R2 Ramp vs XPeng's AI Driving Pivot

• Rivian Leans on Production Scaling: Rivian is gaining on anticipation of its Q2 delivery report as R2 SUV deliveries ramp toward 2026 guidance.

Vinay Lochav | 30 June 2026

Russell Index Reconstitution 2026: Winners and Losers From the Latest Growth and Value Reclassifications

• Promotion Winners See Inflows: Nextpower and Southern Copper benefited from promotion into growth or large-cap benchmarks.

Vinay Lochav | 30 June 2026

Analyst Upgrade Stock Rally: Inside the Biggest Price Target Hikes of Late June 2026

• Dramatic SanDisk Target Increase: Bernstein hiked its target on SanDisk to $3,000 from $1,700, one of the largest single increases of the period.

Vinay Lochav | 30 June 2026

Short Squeeze Candidates 2026: KLA Corporation, Pagaya, and 4D Molecular Therapeutics Show Elevated Short Interest

• KLA Corporation Leads in Short Interest: Short interest above 36% of float has amplified KLA's upside moves following positive catalysts.

Vinay Lochav | 30 June 2026

Biotech Catalyst Roundup 2026: Sarepta, Candel Therapeutics, and 4D Molecular Therapeutics Hit Major Trial Milestones

• FDA Regulatory Acceptance for Sarepta: The FDA accepted supplemental applications for Sarepta's Duchenne treatments, setting a clear PDUFA timeline.

Vinay Lochav | 30 June 2026

GLP-1 Drug Market 2026: How Medicare's Bridge Program Is Reshaping Eli Lilly and Novo Nordisk Stock Sentiment

• Shared Medicare Policy Catalyst: Both companies face the same Bridge program covering their respective GLP-1 drugs at a $50 monthly copay.

Vinay Lochav | 30 June 2026
Support

Hi! How can we help you today?

Loading…